Header Logo

Connection

Joan Lo to HIV Protease Inhibitors

This is a "connection" page, showing publications Joan Lo has written about HIV Protease Inhibitors.
Connection Strength

0.395
  1. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS. 2007 Oct 18; 21(16):2183-90.
    View in: PubMed
    Score: 0.073
  2. Indinavir increases glucose production in healthy HIV-negative men. AIDS. 2004 Sep 03; 18(13):1852-4.
    View in: PubMed
    Score: 0.059
  3. HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):645-7.
    View in: PubMed
    Score: 0.057
  4. The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS. 2004 Mar 05; 18(4):641-9.
    View in: PubMed
    Score: 0.057
  5. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002 Mar 29; 16(5):F1-8.
    View in: PubMed
    Score: 0.050
  6. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS. 2001 May 04; 15(7):F11-8.
    View in: PubMed
    Score: 0.047
  7. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000 Jan 01; 23(1):35-43.
    View in: PubMed
    Score: 0.042
  8. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2001 Apr 15; 26(5):443-8.
    View in: PubMed
    Score: 0.012

© 2025 Kaiser Permanente